Legend Biotech Corporation
LEGN
$35.46
-$0.17-0.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 30.82% | 4.65% | |||
| Total Other Revenue | -96.67% | -59.82% | |||
| Total Revenue | 30.76% | 4.57% | |||
| Cost of Revenue | 13.29% | -2.85% | |||
| Gross Profit | 169.75% | 166.71% | |||
| SG&A Expenses | 11.34% | -12.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.71% | -6.03% | |||
| Operating Income | 56.80% | 32.43% | |||
| Income Before Tax | -25.89% | -344.70% | |||
| Income Tax Expenses | -67.41% | -87.45% | |||
| Earnings from Continuing Operations | -24.24% | -483.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.24% | -483.94% | |||
| EBIT | 56.80% | 32.43% | |||
| EBITDA | 59.58% | 33.06% | |||
| EPS Basic | -23.98% | -482.98% | |||
| Normalized Basic EPS | -26.86% | -317.95% | |||
| EPS Diluted | -23.98% | -482.98% | |||
| Normalized Diluted EPS | -26.86% | -339.53% | |||
| Average Basic Shares Outstanding | 0.20% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.20% | -8.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||